Rilimogene glafolivec
Term · Oncology and biomedicine · MLC-T-ONC-016544
A cancer vaccine consisting of a recombinant fowlpox virus encoding fragment of human prostate-specific antigen (PSA), PSA:154-163 (155L), and a TRIad of COstimulatory Molecules (B7-1, ICAM-1 and LFA-3) (TRICOM). Administration of this agent may induce a cytotoxic T cell response against PSA-expressing tumor cells. Dendritic cells infected with TRICOM vectors greatly enhance naive T-cell activation and peptide-specific T-cell stimulation. Fowlpox virus is an attractive vector because its genome is easy to manipulate and it is replication incompetent in mammalian cells.
| Identifier | MLC-T-ONC-016544 |
|---|---|
| Field | Oncology and biomedicine |
| Synonyms | PROSTVAC-F; recombinant fowlpox-PSA(L155)/TRICOM vaccine |
| References | National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-016544",
"term": "Rilimogene glafolivec",
"field": "Oncology and biomedicine",
"definition": "A cancer vaccine consisting of a recombinant fowlpox virus encoding fragment of human prostate-specific antigen (PSA), PSA:154-163 (155L), and a TRIad of COstimulatory Molecules (B7-1, ICAM-1 and LFA-3) (TRICOM). Administration of this agent may induce a cytotoxic T cell response against PSA-expressing tumor cells. Dendritic cells infected with TRICOM vectors greatly enhance naive T-cell activation and peptide-specific T-cell stimulation. Fowlpox virus is an attractive vector because its genome is easy to manipulate and it is replication incompetent in mammalian cells.",
"synonyms": [
"PROSTVAC-F",
"recombinant fowlpox-PSA(L155)/TRICOM vaccine"
],
"references": [
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/rilimogene-glafolivec/"
}
Record 14,484 of 17,717 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.